CTI BioPharma Corp. Profile Avatar - Palmy Investing

CTI BioPharma Corp.

CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhi…

Biotechnology
US, Seattle [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared CTI BioPharma Corp. (CTIC) to it's peer group.

Peer Group
Loading...
End of CTIC's Analysis
CIK: 891293 CUSIP: 12648L601 ISIN: US12648L6011 LEI: - UEI: -
Secondary Listings
CTIC has no secondary listings inside our databases.